VEGFA and cancer: However, there are also some studies that report arterial thrombosis in cancer patients [138, 139, 140] in the absence of an atherosclerotic plaque, where systemic hypercoagulation induced by factors secreted from cancer cells, such as thrombin and VEGF as well as chemotherapy adverse effects, can be associated with this thrombotic condition [140].